Waldenstrom Macroglobulinemia Complicated with Hyperviscosity Syndrome

Authors

  • Narangerel Jigjidkhorol Center of Hematology and Bone Marrow Transplantation, First Central Hospital, Ulaanbaatar, Mongolia
  • Khishigjargal Batsukh Center of Hematology and Bone Marrow Transplantation, First Central Hospital, Ulaanbaatar, Mongolia
  • Oyundelger Norov Center of Hematology and Bone Marrow Transplantation, First Central Hospital, Ulaanbaatar, Mongolia
  • Myadagsuren Sukhbaatar Center of Hematology and Bone Marrow Transplantation, First Central Hospital, Ulaanbaatar, Mongolia
  • Nansalmaa Ayurzana Center of Hematology and Bone Marrow Transplantation, First Central Hospital, Ulaanbaatar, Mongolia
  • Mend-Amar Ravzanaadii Department of Hematology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia
  • Saruul Tungalag Center of Hematology and Bone Marrow Transplantation, First Central Hospital, Ulaanbaatar, Mongolia
  • Altanshagai Boldbaatar Center of Hematology and Bone Marrow Transplantation, First Central Hospital, Ulaanbaatar, Mongolia
  • Khulan Purevdorj Center of Hematology and Bone Marrow Transplantation, First Central Hospital, Ulaanbaatar, Mongolia
  • Sarantuya Jav Department of Molecular Biology and Genetics, School of Pharmacy and Biomedicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia

DOI:

https://doi.org/10.24079/cajms.2015.01.013

Keywords:

Immunoglobulin M, Plasma Cells, Plasmapheresis

Abstract

Objectives: Waldenstrom Macroglobulinemia (WM) is a malignant disease of the B lymphocytes. We report on a patient in Mongolia having WM complicated with hyperviscosity syndrome. Methods: A 28 year-old Mongolian woman had symptoms due to hyperviscosity syndrome such as vision loss, headache, dizziness and, epistaxis. Upon examination, her morphology, biochemistry, histology, flow cytometry and serum protein electrophoresis indicated WM complicated with hyperviscosity syndrome. Results: The patient was was successfully treated with a combination chemotherapy and plasmapheresis. Conclusion: Hyperviscosity syndrome manifestations should be treated with plasmapheresis.

Downloads

Download data is not yet available.
Abstract
34
PDF
41

Downloads

Published

2015-09-25

How to Cite

Jigjidkhorol, N., Batsukh, K., Norov, O., Sukhbaatar, M., Ayurzana, N., Ravzanaadii, M.-A., Tungalag, S., Boldbaatar, A., Purevdorj, K., & Jav, S. (2015). Waldenstrom Macroglobulinemia Complicated with Hyperviscosity Syndrome. Central Asian Journal of Medical Sciences, 1(1), 81–84. https://doi.org/10.24079/cajms.2015.01.013

Issue

Section

Case Reports